RE:RE:RE:Why PP at lower price!who is blaming the institutional investors? Their were potential problems with biocloud all along, no matter what ghezzi was saying. Alot of people were talking about those problems on these boards, as an investor you should of been aware of those potential problems. When you buy stocks after 1000% runs their is always a huge risk to your investment. Sure Ghezzi overestimated the demand of the product, but the fact is it was an uproven product that didnt exist more than 6 months. Buying at 5 dollars was extremely speculative investment with huge downside potential, and now we are seeing it. The company had 15 million in revenue with a 300 million market cap at those prices, at some point you have to take responsibility for your investment decisions, and not blame everything on the ceo.